Eton Pharmaceuticals, Inc. ETON Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eton Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets?
- Eton Pharmaceuticals, Inc. (ETON) reported deferred tax assets and other non-current assets of $54K in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Eton Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets increased by 350.0% year-over-year, from $12K to $54K.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets has grown at a -13.8% compound annual growth rate (CAGR), from $40K to $19K.